Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-02-06
2007-02-06
Balasubramanian, Venkataraman (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S183000
Reexamination Certificate
active
11167049
ABSTRACT:
In general, the instant invention comprises compounds of Formulas I and IIincluding pharmaceutically acceptable salts thereof. The compounds of the invention are useful as protein kinase inhibitors and therefore are useful for treating cancer and other protein kinase mediated diseases.
REFERENCES:
patent: 3646202 (1972-02-01), Mrozik
patent: 4602912 (1986-07-01), de Sousa et al.
patent: 4663341 (1987-05-01), Jacobson
patent: 4753940 (1988-06-01), Sturm et al.
patent: 4845093 (1989-07-01), Haga et al.
patent: 4908056 (1990-03-01), Tseng
patent: 5132314 (1992-07-01), Maienfisch et al.
patent: 5135949 (1992-08-01), von der Saal et al.
patent: 5646176 (1997-07-01), Golik et al.
patent: 6022884 (2000-02-01), Mantlo et al.
patent: 6143743 (2000-11-01), Wilde et al.
patent: 6143764 (2000-11-01), Kubo et al.
patent: 6214344 (2001-04-01), Schwall et al.
patent: 6232320 (2001-05-01), Stewart et al.
patent: 6262094 (2001-07-01), Hoefle et al.
patent: 6355660 (2002-03-01), Ricks et al.
patent: 6380386 (2002-04-01), Seitz et al.
patent: 6521622 (2003-02-01), Ricks et al.
patent: 6559341 (2003-05-01), Tohnishi et al.
patent: 6603044 (2003-08-01), Tohnishi et al.
patent: 6620827 (2003-09-01), De la Brouse-Elwood et al.
patent: 6670357 (2003-12-01), Leftheris et al.
patent: 6696487 (2004-02-01), Gerusz et al.
patent: 6706740 (2004-03-01), Ricks et al.
patent: 6750246 (2004-06-01), Kadow et al.
patent: 6867300 (2005-03-01), Godfrey, Jr. et al.
patent: 6900208 (2005-05-01), Salvati et al.
patent: 6951859 (2005-10-01), Bhide et al.
patent: 6982265 (2006-01-01), Hunt et al.
patent: 2001/0041673 (2001-11-01), Fossa
patent: 2003/0082631 (2003-05-01), Gustavsson et al.
patent: 2003/0232765 (2003-12-01), Carter et al.
patent: 2003/0232831 (2003-12-01), Dyckman et al.
patent: 2004/0044203 (2004-03-01), Wittman et al.
patent: 2004/0048891 (2004-03-01), Kato et al.
patent: 2004/0053908 (2004-03-01), Funahashi et al.
patent: 2004/0082582 (2004-04-01), Dyckman et al.
patent: 2004/0157846 (2004-08-01), Chen et al.
patent: 2004/0209886 (2004-10-01), Salvati et al.
patent: 2004/0229877 (2004-11-01), Leftheris et al.
patent: 2004/0242603 (2004-12-01), Fujiwara et al.
patent: 2005/0038035 (2005-02-01), Takasugi et al.
patent: 2005/0043306 (2005-02-01), Leftheris et al.
patent: 2005/0107462 (2005-05-01), Godfrey, Jr. et al.
patent: 2005/0143398 (2005-06-01), Das et al.
patent: 2005/0182058 (2005-08-01), Fink et al.
patent: 2005/0239820 (2005-10-01), Borzilleri et al.
patent: 2005/0245530 (2005-11-01), Borzilleri et al.
patent: 2005/0288289 (2005-12-01), Crispino et al.
patent: 2005/0288290 (2005-12-01), Borzilleri et al.
patent: 2006/0003967 (2006-01-01), Shi et al.
patent: 2006/0009454 (2006-01-01), Cai et al.
patent: 2006/0030708 (2006-02-01), Lobben
patent: 200195986 (2002-04-01), None
patent: 31 39 457 (1983-04-01), None
patent: 197 10 609 (1998-09-01), None
patent: 0 151 962 (1985-08-01), None
patent: 0 119 774 (1987-06-01), None
patent: 0 152 910 (1989-07-01), None
patent: 0 919 542 (1999-06-01), None
patent: 1 243 582 (2002-09-01), None
patent: 1 411 046 (2004-04-01), None
patent: 2 106 500 (1983-04-01), None
patent: 54-115384 (1979-09-01), None
patent: 57-51835 (1982-03-01), None
patent: 62-62 (1987-01-01), None
patent: 62-5959 (1987-01-01), None
patent: 62-5960 (1987-01-01), None
patent: 62-135463 (1987-06-01), None
patent: 2003-321472 (2003-11-01), None
patent: 1761753 (1992-09-01), None
patent: WO 97/17329 (1997-05-01), None
patent: WO 98/41513 (1998-09-01), None
patent: WO 99/01454 (1999-01-01), None
patent: WO 99/02514 (1999-01-01), None
patent: WO 99/24404 (1999-05-01), None
patent: WO 00/43366 (2000-07-01), None
patent: WO 00/50405 (2000-08-01), None
patent: WO 00/56738 (2000-09-01), None
patent: WO 00/71129 (2000-11-01), None
patent: WO 00/75145 (2000-12-01), None
patent: WO 01/21576 (2001-03-01), None
patent: WO 01/21596 (2001-03-01), None
patent: WO 01/42243 (2001-06-01), None
patent: WO 01/47890 (2001-07-01), None
patent: WO 01/94353 (2001-12-01), None
patent: WO 02/32872 (2002-04-01), None
patent: WO 02/40486 (2002-05-01), None
patent: WO 02/44156 (2002-06-01), None
patent: WO 02/051397 (2002-07-01), None
patent: WO 02/085859 (2002-10-01), None
patent: WO 03/000194 (2003-01-01), None
patent: WO 03/000660 (2003-01-01), None
patent: WO 03/011028 (2003-02-01), None
patent: WO 03/033472 (2003-04-01), None
patent: WO 03/042172 (2003-05-01), None
patent: WO 03/082208 (2003-10-01), None
patent: WO 03/091229 (2003-11-01), None
patent: WO 03/099286 (2003-12-01), None
patent: WO 2004/001059 (2003-12-01), None
patent: WO 2004/002410 (2004-01-01), None
patent: WO 2004/009542 (2004-01-01), None
patent: WO 2004/032846 (2004-04-01), None
patent: WO 2004/048386 (2004-06-01), None
patent: WO 2004/054514 (2004-07-01), None
patent: WO 2004/058144 (2004-07-01), None
patent: WO 2004/060305 (2004-07-01), None
patent: WO 2004/072030 (2004-08-01), None
patent: WO 2005/005389 (2005-01-01), None
patent: WO 2005/026124 (2005-03-01), None
patent: WO 2005021554 (2005-03-01), None
patent: WO 2005/030140 (2005-04-01), None
patent: WO 2005/042537 (2005-05-01), None
patent: WO 2005/058891 (2005-06-01), None
patent: WO 2005/082854 (2005-09-01), None
patent: WO 2005/082855 (2005-09-01), None
patent: WO 2005/097790 (2005-10-01), None
Cecil Textbook of Medicine, edited by Bennet, J.C., and Plum F., 20th edition,vol. 1, 1004-1010, 1996.
Mass, R. D., Int. J. Radiation Oncology Bio. Phys.vol 58(3): 932-940, 2004.
Fabbro et al. Pharmacology & therapeutics 93, 79-98, 2002.
U.S. Appl. No. 09/573,829, filed May 18, 2000, Hunt et al.
U.S. Appl. No. 11/152,650, filed Jun. 14, 2005, Cai et al.
U.S. Appl. No. 11/168,682, filed Jun. 28, 2005, Shi et al.
U.S. Appl. No. 11/197,970, filed Aug. 5, 2005, Lobben.
U.S. Appl. No. 60/696,394, filed Jul. 1, 2005, Gavai et al.
U.S. Appl. No. 60/703,086, filed Jul. 28, 2005, Norris et al.
Bardelli, A. et al., “Concomitant activation of pathways downstream of Grb2 and PI 3-kinase is required forMET-mediated metastasis”, Oncogene, vol. 18, pp. 1139-1146 (1999).
Barker, J.M. et al., “Thienopyridines. Part 7. Some Electrophilic Substitution Reactions of Thieno[2,3-b]- and -[3,2-b]pyridine Isosteres of 4-Oxygenated and 2,4-Dioxygenated Quinolines”, J. Chem. Research (S), pp. 122-123 (1986).
Bottaro, D.P. et al., “Identification of the Hepatocyte Growth Factor Receptor as thec-metProto-Oncogene Product”, Science, vol. 251, pp. 802-804 (1991).
Bussolino, F. et al., “Hepatocyte Growth Factor Is a Potent Angiogenic Factor Which Stimulates Endothelial Cell Motility and Growth”, The Journal of Cell Biology, vol. 119, No. 3, pp. 629-641 (1992).
Camp, R.L. et al., “MetExpression Is Associated with Poor Outcome in Patients with Axillary Lymph Node Negative Breast Carcinoma”, Cancer, vol. 86, No. 11, pp. 2259-2265 (1999).
Cheng, C.C. et al., “Potential Purine Antagonist. XII. Synthesis of 1-Alkyl(aryl)-4,6-disubstituted Pyrazolo[3-4-d]pyrimidines”, J. Org. Chem., vol. 23, pp. 852-861 (1958).
Chi, S.-M. et al., “Palladium-catalyzed functionalization of 5- and 7-azaindoles”, Tetrahedron Letters, vol. 41, pp. 919-922 (2000).
Christensen, J.G. et al., “A Selective Small Molecule Inhibitor of c-Met Kinase Inhibits c-Met-Dependent Phenotypesin Vitroand Exhibits Cytoreductive Antitumor Activityin Vivo”, Cancer Research, vol. 63, pp. 7345-7355 (2003).
Cooper, C.S. et al., “Amplification and overexpression of the met gene in spontaneously transformed NIH3T3 mouse fibroblasts”, The EMBO Journal, vol. 5, No. 10, pp. 2623-2628 (1986).
Di Renzo, M.F. et al., “Overexpression and Amplification of the Met/HGF Receptor Gene during the Progression of Colorectal Cancer”, Clinical Cancer Research, vol. 1, pp. 147-154 (1995).
Dorn, H. et al., “Unambiguous Synthesis of 4,7-Dihydro-4-oxo-1H-pyrazolo[3,4-b]pyridine—Further Comments on the ‘(N-C)-Rearrangement’ of (2-Alkoxycarbonyl-vinyl-amino) pyrazols”, J. Prakt. Chem., vol. 324, No. 4, pp. 557-562 (1982).
Fry,
Borzilleri Robert M.
Chen Xiao-Tao
Chen Zhong
Hunt John T.
Huynh Tram
Balasubramanian Venkataraman
Bristol--Myers Squibb Company
Gibbons Maureen S.
LandOfFree
Pyrrolotriazine kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrrolotriazine kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrrolotriazine kinase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3833811